These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 231015)
21. Antibodies to Epstein-Barr viral capsid and early antigens associated with Burkitt's lymphoma and lymphoblastic lymphosarcoma in Israel. Gotleib-Stematsky T; Ramot B; Vonsover B; Aghai E; Kende G; Ninio M; Modan M J Natl Cancer Inst; 1976 Apr; 56(4):721-3. PubMed ID: 233958 [TBL] [Abstract][Full Text] [Related]
22. Antibodies to Epstein-Barr virus associated antigens in Burkitt's lymphoma. Gunvén P; Klein G; Henle G; Henle W; Clifford P; Singh S Bibl Haematol; 1973; 39():813-7. PubMed ID: 4360196 [No Abstract] [Full Text] [Related]
23. Association of Epstein-Barr virus and American Burkitt's lymphoma. Easton JM; Ablashi DV; Levine PH; Armstrong GR IARC Sci Publ (1971); 1975; (11 Pt 2):37-43. PubMed ID: 191381 [No Abstract] [Full Text] [Related]
24. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Gunvén P; Klein G; Henle G; Henle W; Clifford P Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656 [No Abstract] [Full Text] [Related]
25. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma. Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896 [TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity. Khyatti M; Patel PC; Stefanescu I; Menezes J J Virol; 1991 Feb; 65(2):996-1001. PubMed ID: 1846213 [TBL] [Abstract][Full Text] [Related]
27. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases. Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211 [TBL] [Abstract][Full Text] [Related]
28. Very late relapses in patients with Burkitt's lymphoma: clinical and serologic studies. Biggar RJ; Nkrumah FK; Henle W; Levine PH J Natl Cancer Inst; 1981 Mar; 66(3):439-44. PubMed ID: 6259398 [TBL] [Abstract][Full Text] [Related]
29. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases]. Gunven P G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758 [No Abstract] [Full Text] [Related]
30. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. Pearson G; Dewey F; Klein G; Henle G; Henle W J Natl Cancer Inst; 1970 Nov; 45(5):989-95. PubMed ID: 18605425 [TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma. Hirshaut Y; Cohen MH; Stevens DA Lancet; 1973 Jul; 2(7821):114-6. PubMed ID: 4124041 [No Abstract] [Full Text] [Related]
32. Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB). Gravell M; Levine PH; McIntyre RF; Land VJ; Pagano JS J Natl Cancer Inst; 1976 Apr; 56(4):701-4. PubMed ID: 176407 [TBL] [Abstract][Full Text] [Related]
33. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma. Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662 [TBL] [Abstract][Full Text] [Related]
34. A case of malignant lymphoma, undifferentiated, Burkitt's type with high antibodies to Epstein-Barr virus. Chen W; Yang KC; Shih JS; Hsu CA; Yeh YS; Chen TY Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Sep; 13(3):343-9. PubMed ID: 6265160 [TBL] [Abstract][Full Text] [Related]
35. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients]. Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138 [TBL] [Abstract][Full Text] [Related]
36. Brief communication: circulating antigen-antibody complex associated with Epstein-Barr virus in recurrent Burkitt's lymphoma. Mukojima T; Gunvén P; Klein G J Natl Cancer Inst; 1973 Oct; 51(4):1319-21. PubMed ID: 4355608 [No Abstract] [Full Text] [Related]
37. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus. Rowe M; Finke J; Szigeti R; Klein G J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572 [TBL] [Abstract][Full Text] [Related]
38. Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals. Seigneurin JM; Lavoue MF; Genoulaz O; Bornkamm GW; Lenoir GM Int J Cancer; 1987 Sep; 40(3):349-53. PubMed ID: 3040599 [TBL] [Abstract][Full Text] [Related]
39. Burkitt's lymphoma in Cuba. I. Clinical and morphological features and EBV association. Riverend E; Rengifo E; Longchong M; Ruíz R; Tormo B; Garćia J; Portero R; Quintero S; Valdés M; Rodríguez T Oncology; 1984; 41(1):13-8. PubMed ID: 6322085 [TBL] [Abstract][Full Text] [Related]
40. [Epstein-Barr virus associated Burkitt's lymphoma in a French child (author's transl)]. Lenoir G; Philip T; Bornkamm GW; Gillet P; Bryon PA; Bouvier R; Dodat H; Doré JF; Brunat-Mentigny M; Hermier M Nouv Presse Med; 1979 Dec; 8(49):4031-3. PubMed ID: 93275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]